Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Gene | CBL |
Variant | R709Q |
Impact List | missense |
Protein Effect | unknown |
Gene Variant Descriptions | CBL R709Q lies within the CD2AP-interacting region of the Cbl protein (UniProt.org). R709Q has been identified in sequencing studies (PMID: 27449473), but has not been biochemically characterized and therefore, its effect on Cbl protein function is unknown (PubMed, Sep 2024). |
Associated Drug Resistance | |
Category Variants Paths |
CBL mutant CBL R709Q |
Transcript | NM_005188.4 |
gDNA | chr11:g.119297007G>A |
cDNA | c.2126G>A |
Protein | p.R709Q |
Source Database | RefSeq |
Genome Build | GRCh38/hg38 |
Transcript | gDNA | cDNA | Protein | Source Database | Genome Build |
---|---|---|---|---|---|
NM_005188.4 | chr11:g.119297007G>A | c.2126G>A | p.R709Q | RefSeq | GRCh38/hg38 |
NM_005188.3 | chr11:g.119297007G>A | c.2126G>A | p.R709Q | RefSeq | GRCh38/hg38 |
NM_005188 | chr11:g.119297007G>A | c.2126G>A | p.R709Q | RefSeq | GRCh38/hg38 |
Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
---|